Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Andrew Ostor"'
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1385-1398 (2023)
Abstract Introduction Recent changes to treatment guidelines for ankylosing spondylitis (AS) have listed first-line advanced therapies as tumor necrosis factor (TNF), interleukin (IL)-17, and Janus kinase (JAK) inhibitors. This study sought to assess
Externí odkaz:
https://doaj.org/article/8c82292463784711937c566a25143db6
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 1, Pp 225-226 (2023)
Externí odkaz:
https://doaj.org/article/df716a744f35459595220e19f42d85c1
Autor:
Philip Mease, Philip Helliwell, Paula Silwinska‐Stanczyk, Malgorzata Miakisz, Andrew Ostor, Elena Peeva, Michael S. Vincent, Qiankun Sun, Vanja Sikirica, Randall Winnette, Ruolun Qiu, Gang Li, Gang Feng, Jean S. Beebe, David A. Martin
Publikováno v:
Arthritis & Rheumatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16469d78a9a53fae37af4f40eaa9cf0a
https://doi.org/10.1002/art.42519
https://doi.org/10.1002/art.42519
Autor:
Xenofon Baraliakos, Roberto Ranza, Andrew Ostor, Francesco Ciccia, Laura C Coates, Simona Rednic, Jessica Walsh, Tianming Gao, Apinya Lertratanakul, In-Ho Song, Fabiana Fabiana Ganz, Kevin Douglas, Atul Deodhar
Publikováno v:
Rheumatology. 62
Background/Aims Patients with PsA and axial involvement have higher disease activity and greater reductions in quality of life; however, there are no accepted criteria for identifying axial involvement in PsA. The objective of this post-hoc analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89b022201392e5e32a443c01f470bc07
https://doi.org/10.1093/rheumatology/kead104.175
https://doi.org/10.1093/rheumatology/kead104.175
Publikováno v:
Rheumatology. 61
Background/Aims Patients (pts) with psoriatic arthritis (PsA) and axial involvement exhibit greater disease activity and quality of life impairments compared with those without axial involvement. Here the aim was to characterize PsA pts with and with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21680c29973beb47cc45bbad2793a3a1
https://doi.org/10.1093/rheumatology/keac132.038
https://doi.org/10.1093/rheumatology/keac132.038
Autor:
Andrew Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Kyle Carter, Vassilis Stakias, Ralph Lippe, Leonidas Drogaris, Ahmed M. Soliman, Michael M. Chen, Byron Padilla, Alan Kivitz
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 633-648 (2024)
Abstract Introduction Long-term therapeutic options providing durable response and tolerability are needed for psoriatic arthritis (PsA). The ongoing KEEPsAKE 2 trial is evaluating risankizumab treatment in patients with active PsA who previously had
Externí odkaz:
https://doaj.org/article/9ce4042ecece4341be994d1a7b7901c4
Autor:
Kim Papp, Ahmed M. Soliman, Christian Kaufmann, Lisa Barcomb, Zailong Wang, Douglas White, Andrew Ostor, Lars Erik Kristensen
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35749a7296d485412be7b3840b52c78d
https://doi.org/10.1016/j.jaad.2022.06.729
https://doi.org/10.1016/j.jaad.2022.06.729
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8349d7fce651ae978adfec90bfff9966
https://doi.org/10.1016/j.jaad.2022.06.230
https://doi.org/10.1016/j.jaad.2022.06.230
Autor:
Rieke Alten, Gerd R. Burmester, Marco Matucci-Cerinic, Jean-Hugues Salmon, Andrew Östör, Khai Jing Ng, Jens Gerwien, Liliana Zaremba-Pechmann, Alan J. M. Brnabic, Bruno Fautrel
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1575-1595 (2023)
Abstract Introduction RA-BE-REAL is a 3-year, multinational, prospective, observational study of adult patients with rheumatoid arthritis (RA) evaluating time to discontinuation of initial RA treatment along with patient baseline characteristics. Thi
Externí odkaz:
https://doaj.org/article/63d5ff311b2441d18921c0a0894d1ffb
Autor:
Xenofon Baraliakos, Roberto Ranza, Andrew Östör, Francesco Ciccia, Laura C. Coates, Simona Rednic, Jessica A. Walsh, Kevin Douglas, Tianming Gao, Koji Kato, In-Ho Song, Fabiana Ganz, Atul Deodhar
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background The objective of this post-hoc analysis was to assess the efficacy and safety of upadacitinib in psoriatic arthritis (PsA) patients with axial involvement. Methods Post-hoc analysis of SELECT-PsA 1 and SELECT-PsA 2 in patients ran
Externí odkaz:
https://doaj.org/article/90d18e6abacf401699f4e7aeeb68ccd1